Literature DB >> 2830725

Cancer of the extrahepatic bile duct: a clinicopathologic study of immunohistochemistry for CEA, CA19-9, and p21.

K Yamaguchi, M Enjoji, F Nakayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2830725     DOI： 10.1007/BF01658480

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  24 in total

1.  PRIMARY CARCINOMA OF THE EXTRAHEPATIC BILE DUCTS.

Authors:  J M HAM; D C MACKENZIE
Journal:  Surg Gynecol Obstet       Date:  1964-05

2.  Carcinoma of the bile ducts.

Authors:  B THORBJARNARSON
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

3.  Carcinoma of the major intrahepatic and the extrahepatic bile ducts exclusive of the papilla of Vater.

Authors:  K KUWAYTI; A H BAGGENSTOSS; M H STAUFFER; J T PRIESTLEY
Journal:  Surg Gynecol Obstet       Date:  1957-03

4.  Carcinoma of the extrahepatic bile ducts; review of the literature and report of six cases.

Authors:  K SAKO; G L SEITZINGER; E GARSIDE
Journal:  Surgery       Date:  1957-03       Impact factor: 3.982

5.  Expression of the antigen detected by the monoclonal antibody Ca 19.9 in human breast tissues.

Authors:  R A Walker; S J Day
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.

Authors:  E Tahara; W Yasui; K Taniyama; A Ochiai; T Yamamoto; S Nakajo; M Yamamoto
Journal:  Jpn J Cancer Res       Date:  1986-06

7.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

8.  Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

Authors:  P H Hand; A Thor; D Wunderlich; R Muraro; A Caruso; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.

Authors:  M Dietel; H Arps; R Klapdor; S Müller-Hagen; M Sieck; L Hoffmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  Surgical treatment of adenocarcinoma. Location: junction of the right, left, and common hepatic biliary ducts.

Authors:  O E Akwari; K A Kelly
Journal:  Arch Surg       Date:  1979-01
View more
  5 in total

1.  Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation.

Authors:  M Miros; P Kerlin; N Walker; J Harper; S Lynch; R Strong
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

2.  High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.

Authors:  M Watanabe; M Chigusa; H Takahashi; J Nakamura; H Tanaka; T Ohno
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

3.  Adenoma of the ampulla of Vater: putative precancerous lesion.

Authors:  K Yamaguchi; M Enjoji
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

4.  Frozen section and permanent diagnoses of the bile duct margin in gallbladder and bile duct cancer.

Authors:  Koji Yamaguchi; Kengo Shirahane; Masafumi Nakamura; Dongming Su; Hiroyuki Konomi; Kentaro Motoyama; Atsushi Sugitani; Kazuhiro Mizumoto; Masao Tanaka
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

5.  Prognostic factors following surgical resection of distal bile duct cancer.

Authors:  Young Jae Chung; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo; Dong Hun Kim
Journal:  J Korean Surg Soc       Date:  2013-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.